V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012410 | 240008601 | 1.73 | null | Palliative (P) | 2014-04-17 | 2014-06-11 | R CODOX-M/ R IVAC | N | N | 240005033 | RUXOLITINIB |
| 240012411 | 240008602 | 1.6 | 85.4 | Curative (C) | 2014-07-09 | 2014-07-09 | Cisplatin + Docetaxel | N | N | 240005082 | GEMCITABINE + OXALIPLATIN |
| 240012412 | 240008606 | 1.75 | 58.5 | Curative (C) | 2018-01-09 | 2018-01-09 | CARMUSTINE + THIOTEPA | null | N | 240005321 | CLOFARABINE + CYTARABINE |
| 240012413 | 240008607 | 0 | 42.9 | Curative (C) | 2017-11-28 | 2017-12-21 | BORTEZOMIB + THALIDOMIDE | null | null | 240005364 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 240012414 | 240008608 | 1.59 | 59.9 | Curative (C) | 2015-03-09 | 2015-04-07 | LENALIDOMIDE + RITUXIMAB | N | null | 240005364 | CISPLATIN + PACLITAXEL |
| 240012415 | 240008608 | 1.66 | 95.3 | Disease modification (D) | 2015-06-02 | 2015-06-15 | AML16 DA 3+10 | N | null | 240005364 | CARBOPLATIN + DOCETAXEL |
| 240012416 | 240008608 | null | null | Curative (C) | 2013-10-14 | 2013-10-17 | ETOPOSIDE | N | N | 240005364 | GEMCITABINE + PACLITAXEL |
| 240012417 | 240016152 | 1.69 | 63.15 | Palliative (P) | 2015-08-30 | 2015-08-30 | CRIZOTINIB | N | N | 240005553 | CETUXIMAB |
| 240012418 | 240008609 | 1.84 | 89.4 | Palliative (P) | 2016-08-04 | 2017-07-26 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | N | 240005562 | IPILIMUMAB |
| 240012419 | 240008610 | 1.8 | null | Curative (C) | 2015-08-14 | 2015-08-16 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 240005583 | R-EPOCH |
| 240012420 | 240008611 | 1.57 | null | Curative (C) | 2017-04-22 | 2017-04-26 | IMATINIB | N | N | 240005643 | CODOX M |
| 240012421 | 240008612 | null | 71 | Palliative (P) | 2015-01-08 | 2015-01-15 | R-PMitCEBOM | 02 | N | 240005838 | NHL 2003 |
| 240012422 | 240008613 | null | 67 | Curative (C) | 2014-08-16 | 2014-08-25 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 240005841 | ESHAP |
| 240012423 | 240008614 | 1.82 | 99.8 | Palliative (P) | 2016-11-29 | 2016-11-29 | NHL 2003 Gp C COPADM 2 | N | N | 240005884 | TRIPLE INTRATHECAL |
| 240012424 | 240008615 | 1.6 | 63 | Palliative (P) | null | 2018-03-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 240005912 | TEMOZOLOMIDE |
| 240012425 | 240012604 | 1.57 | 76.4 | Curative (C) | 2019-01-07 | 2019-01-08 | AML 19 TRIAL | 02 | null | 240005996 | CYTARABINE HD + METHOTREXATE HD |
| 240012426 | 240012604 | 1.71 | 77 | Disease modification (D) | 2016-10-14 | 2016-10-16 | Triple Intrathecal | N | N | 240005996 | AML19 TRIAL |
| 240012427 | 240012604 | 1.73 | null | Palliative (P) | null | 2018-06-13 | CISPLATIN + FLUOROURACIL | N | N | 240005996 | LENALIDOMIDE + RITUXIMAB |
| 240012428 | 240008617 | 1.65 | 62.3 | Curative (C) | 2017-01-04 | 2017-01-11 | Carboplatin + Topotecan | N | N | 240006303 | CRIZOTINIB |
| 240012429 | 240008618 | 1.72 | 75 | Curative (C) | 2014-05-11 | 2014-05-18 | PEMBROLIZUMAB | 02 | N | 240006303 | CLADRIBINE |
| 240012430 | 240012606 | 1.54 | 68 | Curative (C) | 2018-05-13 | 2018-05-14 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 240006341 | BEVACIZUMAB + CARBO |
| 240012431 | 240012606 | 1.61 | 80.9 | Curative (C) | 2018-12-29 | 2018-12-29 | ATG + Busulfan + Fludarabine + Thiotepa | 02 | N | 240006341 | CARMUSTINE + CYTARABINE + ETOPOSIDE |
| 240012432 | 240008620 | 1.83 | null | Palliative (P) | 2015-03-31 | 2015-04-01 | CHOEP | N | N | 240006383 | VEDEX |
| 240012433 | 240008621 | 1.61 | 39.6 | Palliative (P) | 2017-05-08 | 2017-05-08 | Dacarbazine | 2 | N | 240006383 | AML18 TRIAL |
| 240012434 | 240008622 | null | null | Palliative (P) | 2014-08-14 | 2014-08-17 | Pemetrexed | N | null | 240006436 | VINBLASTINE |
| 240012436 | 240012608 | null | 52.5 | Curative (C) | 2017-06-26 | 2017-06-26 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 240006577 | CLADRIBINE |
| 240012437 | 240008625 | 1.66 | null | Curative (C) | 2018-04-29 | 2018-04-30 | RUXOLITINIB | N | N | 240006607 | RUXOLITINIB |
| 240012438 | 240008626 | 1.6 | null | Curative (C) | 2019-01-22 | 2019-01-22 | TOPOTECAN | 2 | N | 240006614 | CYTARABINE + METHOTREXATE + RITUXIMAB |
| 240012439 | 240008627 | 1.6 | 81.8 | Curative (C) | 2016-04-07 | 2016-05-10 | PMitCEBO-R | 1 | null | 240006614 | RUXOLITINIB |
| 240012440 | 240014484 | null | 82.3 | Curative (C) | 2017-03-30 | 2017-04-12 | Escalated BEACOPP | N | N | 240006831 | ICE-R |
| 240012441 | 240014484 | 1.65 | 67.1 | Palliative (P) | 2014-12-18 | 2014-12-24 | Etoposide IV | N | null | 240006831 | CAV |
| 240012442 | 240014484 | 1.8 | 76.4 | Curative (C) | 2016-09-30 | 2017-01-04 | ESHAP R | 2 | N | 240006831 | LIPOSOMAL DOXORUBICIN |
| 240012443 | 240008628 | 1.71 | 77 | Disease modification (D) | 2015-05-02 | 2015-05-09 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240007017 | ESHAP R |
| 240012444 | 240008629 | 1.77 | 72.8 | Disease modification (D) | 2016-07-04 | 2016-08-01 | GEM-P | N | N | 240007170 | CODOX M |
| 240012445 | 240012612 | 1.52 | 61 | Curative (C) | 2017-06-09 | 2017-06-15 | Triple Intrathecal | 02 | N | 240007193 | CAPECITABINE + MITOMYCIN |
| 240012446 | 240012612 | 1.79 | 85.2 | Palliative (P) | 2017-05-27 | 2017-07-04 | R-GEM-P | N | null | 240007193 | CHLORAMBUCIL + OBINUTUZUMAB |
| 240012447 | 240008631 | 1.77 | 89.4 | Curative (C) | 2017-11-26 | 2017-11-26 | AML 19 TRIAL | N | N | 240007284 | UKALL2011 |
| 240012448 | 240008632 | 1.53 | null | Curative (C) | 2017-05-01 | 2017-05-08 | R-GEM-P | 1 | N | 240007284 | ECX |
| 240012449 | 240008633 | null | 105.5 | Curative (C) | 2016-08-21 | 2016-09-02 | RCEOP | 02 | null | 240007399 | GEMCITABINE + OXALIPLATIN |
| 240012450 | 240008638 | 1.57 | 73 | Palliative (P) | 2016-03-21 | 2016-03-25 | CARMUSTINE + THIOTEPA | N | Y | 240007447 | CLADRIBINE |
| 240012451 | 240012614 | 1.61 | 48.4 | Palliative (P) | 2019-01-04 | 2019-01-06 | Carboplatin + Topotecan | N | Y | 240007531 | CARMUSTINE + THIOTEPA |
| 240012452 | 240015908 | null | 63.15 | Curative (C) | null | 2016-04-03 | IVE | N | N | 240007767 | CVD |
| 240012453 | 240008642 | 1.5 | 97.8 | Curative (C) | 2017-11-02 | 2017-11-03 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL | N | N | 240007811 | CTD |
| 240012454 | 240008642 | 1.67 | 84.3 | Palliative (P) | 2016-12-28 | 2016-12-28 | CRIZOTINIB | N | N | 240007811 | CVP |
| 240012455 | 240008643 | 1.59 | 63 | Curative (C) | 2017-11-26 | 2017-11-28 | AML 19 TRIAL | 2 | null | 240007918 | CYTARABINE HD + METHOTREXATE HD |
| 240012456 | 240016153 | null | null | Disease modification (D) | 2019-03-25 | 2019-04-07 | VEDex | N | N | 240007996 | ABVD R |
| 240012457 | 240008644 | null | 63 | Curative (C) | 2019-03-13 | 2019-03-18 | Trabectedin | 02 | N | 240008056 | UKALL60+ |
| 240012458 | 240008646 | 1.7 | 89 | Disease modification (D) | 2015-03-17 | 2015-03-17 | Alemtuzumab | N | N | 240008056 | IDELALISIB + RITUXIMAB |
| 240012459 | 240015425 | 1.73 | 53.8 | Curative (C) | 2015-11-06 | 2015-11-13 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | 240008242 | BENDAMUSTINE + OBINUTUZUMAB |
| 240012460 | 240008647 | 1.57 | 57.8 | Neo-adjuvant (N) | 2017-10-29 | 2017-11-13 | Trifluridine + Tipiracil | N | N | 240008265 | CARBOPLATIN + RT |